ABIOMED Inc. (ABMD)

267.74
NASDAQ : Health Technology
Prev Close 261.04
Day Low/High 260.01 / 268.72
52 Wk Low/High 112.20 / 268.72
Avg Volume 342.70K
Exchange NASDAQ
Shares Outstanding 44.28M
Market Cap 10.35B
EPS 1.20
P/E Ratio 131.18
Div & Yield N.A. (N.A)

Latest News

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

For the past 11 years, FANG stocks have outperformed in years that end in an odd number and underperformed in years that end with an even number. That's not good news moving into 2018.

Closing the Door on Abiomed

Closing the Door on Abiomed

It's good as a long-term name, but as an options trade, it's time to go.

Capturing Profits on AIG

Capturing Profits on AIG

Let's roll with the sure thing and not wait for expiry.

A Roundup of My Open Positions

A Roundup of My Open Positions

Update on the last few Action Alerts Options trades.

Pumped Up About Abiomed Collar Play

Pumped Up About Abiomed Collar Play

The producer of heart pumps also is an interesting name for the longer term.

Abiomed Announces Q1 FY 2018 Revenue Of $132.5 Million, Up 29% Over Prior Year

Abiomed Announces Q1 FY 2018 Revenue Of $132.5 Million, Up 29% Over Prior Year

Company announces Japanese reimbursement for Impella® heart pumps and raises lower end of FY 2018 revenue guidance

Heart Recovery Patients Visit Capitol Hill To Advocate For Lifesaving Cardiovascular Technology

Patients recovered their native hearts with the help of Impella®, the world's smallest heart pump

Abiomed Introduces 3rd Generation Impella CP® Heart Pumps At SCAI 2017

Designed to Enable Ease of Use in High-Risk Percutaneous Coronary Interventions and in the ICU

Abiomed Marks Grand Opening Of Newly-Expanded Headquarters In Danvers, Massachusetts

Governor Baker joins heart recovery leader for grand opening of new manufacturing and training space that represents major investment in Massachusetts

Abiomed's Impella® Technology Showcased At 2017 American College Of Cardiology Scientific Session With More Than 10 Presentations

First Ever Scientific Presentation of Abiomed's Impella® Quality (IQ) Assurance Program

TheStreet Quant Rating: B (Buy)